ARGX:NASDAQ
argenx SE - ADR
$1,001.24
arrow_upward
+1.71%(+16.85) 1D
Sep 14, 10:54:42 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$1,004.56
High
$1,008.32
Low
$988.88
Mkt. cap
63.08B
Avg. vol.
279.47K
Volume
37.10K
P/E ratio
38.04
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
Open
$1,004.56
High
$1,008.32
Low
$988.88
Mkt. cap
63.08B
Avg. vol.
279.47K
Volume
37.10K
P/E ratio
38.04
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
Investing.com
·
48 minutes ago
argenx at Morgan Stanley conference: broadening beyond vyvgart
ad-hoc-news.de
·
1 hour ago
Argenx stock holds strong as key biotech holding with robust market value
ad-hoc-news.de
·
3 days ago
Argenx stock trades near 12-month high as analysts see further upside
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR